Abstract:
The invention relates to a method for preparing fluoropropenes of formula (I) CF3CF═CHR, where R is a hydrogen or a fluorine atom from at least one compound of formula (Ia) CF3CF═CFR, where R has the same meaning as in formula (I), said method including the following steps: (i) hydrogenating at least one compound of formula (Ia) in an adiabatic reactor in the presence of a catalyst with a superstoichiometric amount of hydrogen so as to produce a hydrofluoropropane; (ii) partially condensing the flow from the adiabatic reactor of step (i) so as to produce a gaseous phase fraction, including unreacted hydrogen and a portion of the formed hydrofluoropropane, which is recirculated to step (i), and a liquid phase fraction including the residue of the hydrofluoropropane; (iii) dehydrofluorinating hydrofluoropropane from the liquid fraction of step (ii) using potassium hydroxide in an aqueous reaction medium contained in an agitated reactor so as to produce the fluoropropene of formula (I); and (iv) purifying the fluoropropene obtained in step (iii).
Abstract:
A composition contains (A) a hydrosilylation reaction catalyst and (B) an aliphatically unsaturated compound having an average, per molecule, of one or more aliphatically unsaturated organic groups capable of undergoing hydrosilylation reaction. The composition is capable of reacting via hydrosilylation reaction to form a reaction product, such as a silane, a gum, a gel, a rubber, or a resin. Ingredient (A) contains a platinum-ligand complex that can be prepared by reacting a platinum precursor and a ligand.
Abstract:
A composition is capable of curing via condensation reaction. The composition uses a sulfonic acid condensation reaction catalyst. The sulfonic acid condensation reaction catalyst is used to replace conventional tin catalysts. The composition can react to form a gum, gel, or rubber.
Abstract:
A composition is capable of curing via condensation reaction. The composition uses a phosphate condensation reaction catalyst. The phosphate condensation reaction catalyst is used to replace conventional tin catalysts. The composition can react to form a gum, gel, or rubber.
Abstract:
Targeted binding agents, such antibodies directed to the antigen αVβ6 and uses of such agents are described. In particular, fully human monoclonal antibodies directed to the antigen αVβ6 are disclosed. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3 are disclosed. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also disclosed.
Abstract:
A subject-matter of the invention is a process for the preparation of 2,3,3,3-tetrafluoro-1-propene comprising the following stages: (i) hydrogenation of hexafluoropropylene to give 1,1,1,2,3,3-hexafluoropropane; (ii) dehydrofluorination of the 1,1,1,2,3,3-hexafluoropropane obtained in the preceding stage to give 1,2,3,3,3-pentafluoro-1-propene; (iii) hydrogenation of the 1,2,3,3,3-pentafluoro-1-propene obtained in the preceding stage to give 1,1,1,2,3-pentafluoropropane; (iv) purification of the 1,1,1,2,3-pentafluoropropane obtained in the preceding stage; and (v) dehydrofluorination of the 1,1,1,2,3-pentafluoropropane obtained in the preceding stage to give 2,3,3,3-tetrafluoro-1-propene; and (vi) purification of the 2,3,3,3-tetrafluoro-1-propene of the preceding stage.
Abstract:
Driving mechanism for watch movement having: a barrel mounted on an arbor so as to be capable of turning around an axis of the arbor when the driving mechanism is wound up. A mainspring unit has a first and second spring coiled up inside the barrel in superimposed fashion and coaxial one relative to the other. The first and second springs are coupled at one of their extremities to the barrel and to the arbor, respectively. The unit has a plate mounted coaxially between the two springs, and mounted rotatively on the axis. The first and second springs are coupled at their other extremity to the centre and to the periphery of the plate, respectively, so that the two springs simultaneously wind up around the axis when the driving mechanism is wound up.
Abstract:
The invention relates to a device (1) enabling the exchange of heat between a first fluid (2) and a second fluid (3) flowing counter current through the device, comprising: an outer casing (4) sealed against the two fluids, having a long shape that extends between first (7) and second (9) ends; a wall (5) enabling heat exchange between the fluids, housed inside the outer casing; a first inlet (6) for the first fluid (2), formed at the first end (7) of the outer casing; a second inlet (8) for the second fluid (3), formed at the second end (9) of the outer casing (4) opposite the first end (7), the aforementioned exchange wall (5) extending between the first (6) and second (8) fluid inlets; a first outlet (10) for extracting the first fluid (2) from the outer casing (4), formed in the area at the first end (7); a second outlet (11) for extracting the second fluid (3) from the outer casing (4), formed in the area at the second end (9); a first pipe (12) enabling the flow of the first fluid (2) inside the outer casing (4); and a second pipe (13) enabling the flow of the second fluid (3) inside the outer casing (4), such that (i) the second outlet (11) and the first inlet (6) and (ii) the first outlet (10) and the second inlet (8) are separated respectively by a distance equal to or greater than the length (□) of the exchange wall. The invention also relates to the different uses of the device.
Abstract:
Targeted binding agents, such antibodies directed to the antigen αVβ6 and uses of such agents are described. In particular, fully human monoclonal antibodies directed to the antigen αVβ6 are disclosed. Nucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions and/or complementarity determining regions (CDR's), specifically from FR1 through FR4 or CDR1 through CDR3 are disclosed. Hybridomas or other cell lines expressing such immunoglobulin molecules and monoclonal antibodies are also disclosed.
Abstract:
The building material, in one embodiment, has a jointing system that is uniquely configured to cover the frame of a structure. This building material, in one embodiment, is a building board with a conforming flange that is embossed onto the board and adapted to engage or mate with an end of an adjacent board. In another embodiment, the building material is an engineered panel joint comprised of a building board and a flexible or hinged article attached to the back surface of the building board. The article is preferably attached to the building board by an adhesive and extends beyond the edge and away from the building board for receiving a fastener to fix the building board to the structure. The fastener is preferably a nail. Components of the building material are preferably attached to the frame of the structure through the use of a single row of nails while maintaining or enhancing the shear strength performance of the building board system.